Skip to main content

How paclitaxel can improve results in diabetics.

Publication ,  Journal Article
Cafasso, D; Schneider, P
Published in: J Cardiovasc Surg (Torino)
February 2012

Despite advances in endovascular techniques, the success of these revascularization procedures is limited by neointimal hyperplasia and subsequent restenosis or occlusion. Infrainguinal interventions have higher rates of restenosis after intervention in comparison to other vascular beds, and this is likely due to a host of anatomic, mechanical, biological and rheological factors that create a relatively hostile environment for the restoration of lower extremity perfusion through endovascular means. In addition, outcomes in the diabetic subpopulation are even worse, with a higher risk of amputation, re-interventions, and failed procedures in critical limb ischemia. Novel techniques for antiproliferative drug release into the vessel wall at the site of endovascular intervention have shown promising results in combating restenosis in the coronary arteries and data are accumulating to suggest promise in the infrainguinal arteries as well. The application of paclitaxel, delivered either through drug coated balloons or drug-eluting stents, has demonstrated benefit in enhanced durability of lower extremity endovascular procedures, and may be of particular advantage concerning diabetic limb salvage. This review presents an overview of the current literature and ongoing trials with the use of paclitaxel in diabetic lower extremity occlusive disease.

Duke Scholars

Published In

J Cardiovasc Surg (Torino)

EISSN

1827-191X

Publication Date

February 2012

Volume

53

Issue

1

Start / End Page

13 / 21

Location

Italy

Related Subject Headings

  • Vascular Patency
  • Treatment Outcome
  • Paclitaxel
  • Humans
  • Drug-Eluting Stents
  • Diabetic Foot
  • Cardiovascular System & Hematology
  • Antineoplastic Agents, Phytogenic
  • Angioplasty, Balloon
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Cafasso, D., & Schneider, P. (2012). How paclitaxel can improve results in diabetics. J Cardiovasc Surg (Torino), 53(1), 13–21.
Cafasso, D., and P. Schneider. “How paclitaxel can improve results in diabetics.J Cardiovasc Surg (Torino) 53, no. 1 (February 2012): 13–21.
Cafasso D, Schneider P. How paclitaxel can improve results in diabetics. J Cardiovasc Surg (Torino). 2012 Feb;53(1):13–21.
Cafasso, D., and P. Schneider. “How paclitaxel can improve results in diabetics.J Cardiovasc Surg (Torino), vol. 53, no. 1, Feb. 2012, pp. 13–21.
Cafasso D, Schneider P. How paclitaxel can improve results in diabetics. J Cardiovasc Surg (Torino). 2012 Feb;53(1):13–21.

Published In

J Cardiovasc Surg (Torino)

EISSN

1827-191X

Publication Date

February 2012

Volume

53

Issue

1

Start / End Page

13 / 21

Location

Italy

Related Subject Headings

  • Vascular Patency
  • Treatment Outcome
  • Paclitaxel
  • Humans
  • Drug-Eluting Stents
  • Diabetic Foot
  • Cardiovascular System & Hematology
  • Antineoplastic Agents, Phytogenic
  • Angioplasty, Balloon
  • 3202 Clinical sciences